(Q37219379)

19 August 2017

0 references

1 reference

title

Pharmacological interventions for the prevention of relapse in bipolar disorder: a systematic review of controlled trials (English)

1 reference

19 August 2017

1 reference

1 reference

1 reference

2

K Soares-Weiser

1 reference

19 August 2017

S Beynon

1

1 reference

19 August 2017

N Woolacott

series ordinal

3

1 reference

19 August 2017

S Duffy

series ordinal

4

1 reference

19 August 2017

J R Geddes

series ordinal

5

1 reference

19 August 2017

language of work or name

English

0 references

publication date

17 July 2008

1 reference

Journal of Psychopharmacology

19 August 2017

1 reference

19 August 2017

23

1 reference

19 August 2017

5

1 reference

19 August 2017

574-591

1 reference

Comparative evaluation of olanzapine efficacy in the maintenance treatment of bipolar disorder

19 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093885

Efficacy and tolerability of quetiapine in the treatment of bipolar disorder: preliminary evidence from a 12-month open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093885

A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093885

A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093885

A 20-month, double-blind, maintenance trial of lithium versus divalproex in rapid-cycling bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093885

A Double-Blind, Placebo-Controlled, Prophylaxis Study of Lamotrigine in Rapid-Cycling Bipolar Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093885

Lithium carbonate and affective disorders. V: A double-blind study of prophylaxis of depression in bipolar illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093885

Current management of bipolar affective disorder: is it reflective of the BAP guidelines?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093885

Double-blind 18-month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093885

Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093885

An emotional Stroop functional MRI study of euthymic bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093885

Antidepressants for bipolar depression: a systematic review of randomized, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093885

Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093885

The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of Mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093885

Combination tricyclic antidepressant and lithium maintenance medication in unipolar and bipolar depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093885

Lithium carbonate and imipramine in the prophylaxis of unipolar and bipolar II illness: a prospective, placebo-controlled comparison.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093885

Minimum plasma lithium levels required for effective prophylaxis in DSM III bipolar disorder: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093885

Factors associated with treatment success in lithium carbonate prophylaxis. Report of the Veterans Administration and National Institute of Mental Health collaborative study group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093885

Lithium carbonate and imipramine in prevention of affective episodes. A comparison in recurrent affective illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093885

Effectiveness and medical costs of divalproex versus lithium in the treatment of bipolar disorder: results of a naturalistic clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093885

A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093885

Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093885

Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093885

Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093885

Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093885

Acute and maintenance treatment of bipolar mania: the role of atypical antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093885

Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093885

Double-blind comparison of the continued use of antipsychotic treatment versus its discontinuation in remitted manic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093885

21 January 2018

Identifiers

DOI

10.1177/0269881108093885

1 reference

19 August 2017

1 reference